Abcam Finance is used to expand the research bio-reagent sales platform

Aabcam completed a 200m-pound capital raise on May 15th to support its expansion in China and the US to fund the company's new acquisition. HSBC UK acted as an agent and co-lead for the financing. HSBC has also provided abcam with revolving credit to help it develop new technologies and expand its market.Gavin Wood, Abam's chief financial officer, said: "At this time, new research and breakthroughs will lead to more accurate diagnostic techniques, better treatment outcomes, and a more active life sciences industry. Based on this, Abcam will have more opportunities to expand the market. We want to expand through investments and acquisitions and are delighted to have HSBC's support. Jason Smithers head of HSBC, said: "Abcam's strength and customer-centric strategy will open the door to a market of about $8bn. Itthat Abcam previously completed $1.8 million in venture capital in January 2011, listed on the London Stock Exchange on September 5, 2008, and completed a $77 million IPO in April 2012.Founded in 1998 by Dr. Jonathan Milner, Abcam is a research antibody and related protein production and distribution company dedicated to the production and supply of high-quality biological reagents to help life scientists conduct basic research, disease diagnosis research, and drug development. Headquartered in Cambridge, UK, the company has offices in Eugene, Cambridge, Tokyo, Japan and Hong Kong, China, serving customers in more than 140 countries around the world. As it continues to grow, Abcam has become an industry leader with an annual turnover of more than 60 million pounds and is growing. The key to its success is the speed and business efficiency with which products are brought to market. Abcam won the inaugural China-UK Awards at businessweek in March.are essential tools for life scientists to analyze the composition of living cells at the molecular level. Abcam built an online antibody store that revolutionized the way customers buy antibodies. Its online marketer contains tens of thousands of products and provides hundreds of thousands of pages of data. With its business in protein detection and the expansion of the global market, the company already has a range of anti-, secondary, immunometric and cell testing kits, protein/polypeptides, antagonists/antagonists/active agents/inhibitors, and lysates, including oncology research, cardiovascular research, cell biology, chromatin and cellular signal transduction research, developmental biology, immunology, metabolism, microbiology, neurobiology, signal transduction research, and stem cell research.Abcam provides high-quality protein research tools and specialized technical support for cutting-edge research areas such as cancer, cardiovascular disease, chromosomes, immunology, neuroscience, and stem cells - scientists can quickly find specific products through Abcam to accelerate the pace of disease research.About HSBC Holdings (HSBC Holdings p.m., HSBC)HSBC was founded in 1865 and is one of the world's largest banking and financial services institutions with approximately 8,000 offices in 87 countries and territories in Europe, Asia Pacific, the Americas, the Middle East and Africa.HSBC is listed on the London, Hong Kong, New York, Paris and Bermuda stock exchanges and has more than 220,000 shareholders from 119 countries and territories. Through its professional international network and e-commerce business, HSBC provides clients with a wide range of financial services, including personal finance, commercial banking, investment banking, private banking, etc. (Arterial mesh)